A Phase 2, Exploratory Study to Investigate Safety and Efficacy of Doxycycline Monohydrate Hydrogel (NANODOX® HYDROGEL 1%) In Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Doxycycline (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- 07 Sep 2017 Planned number of patients changed from 15 to 20.
- 18 May 2017 Status changed from not yet recruiting to recruiting.
- 14 Apr 2017 Planned initiation date changed from 28 Feb 2017 to 1 May 2017.